季线金叉,月线KDJ已掉头向上,大底部持续放量,从历史最低点仅上涨一倍,待利好消息逐步释放,20倍以上目标可待。查看全文
利弗魔尔2021-03-12 02:04
$Invivo治疗控股(NVIV)$ 神经脊髓支架,这个有科技含量啊,异动,估计很快有更大动作,4000万市值,目标3倍。$苹果(AAPL)$ $特斯拉(TSLA)$查看全文
chuminhua2021-03-03 16:37
3月2日,Inovio Pharmaceuticals宣布,其基于DNA的在研HPV免疫疗法VGX-3100在一项后期试验中达到了可评估受试者的主要和次要终点,可作为与人乳头瘤病毒(HPV)相关的高级别鳞状上皮内病变(HSIL)的潜在疗法。首席执行官J.Joseph Kim提出,如果获得批准,VGX-3100有可能 "成为受HPV-16-/18相...查看全文
$Invivo治疗控股(NVIV)$ EFFECT - Notice of Effectiveness Filed: 2019-06-28 AccNo: 9999999995-19-001468 Size: 1 KB 网页链接
$Invivo治疗控股(NVIV)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-06-21 AccNo: 0001104659-19-036827 Size: 387 KB 网页链接
$Invivo治疗控股(NVIV)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-06-14 AccNo: 0001558370-19-005695 Size: 73 KB 网页链接
$Invivo治疗控股(NVIV)$ 8-K - Current report Filed: 2019-06-14 AccNo: 0001558370-19-005696 Size: 73 KBItem 5.07: Submission of Matters to a Vote of Security HoldersItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Invivo治疗控股(NVIV)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-06-05 AccNo: 0001558370-19-005502 Size: 38 KB 网页链接
$Invivo治疗控股(NVIV)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-06-05 AccNo: 0001558370-19-005504 Size: 101 KB 网页链接
$Invivo治疗控股(NVIV)$ EFFECT - Notice of Effectiveness Filed: 2019-05-28 AccNo: 9999999995-19-001218 Size: 1 KB 网页链接
$Invivo治疗控股(NVIV)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-05-17 AccNo: 0001558370-19-005188 Size: 68 KB 网页链接
$Invivo治疗控股(NVIV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-10 AccNo: 0001558370-19-004777 Size: 5 MB 网页链接
$Invivo治疗控股(NVIV)$ DEF 14A - Other definitive proxy statements Filed: 2019-04-25 AccNo: 0001558370-19-003326 Size: 1 MB 网页链接